British Columbia Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22M | Sell |
783,617
-225,257
| -22% | -$6M | 0.13% | 130 |
|
|
2025
Q4 | $25.1M | Buy |
1,008,874
+190,855
| +23% | +$4.81M | 0.13% | 146 |
|
|
2025
Q3 | $20.8M | Sell |
818,019
-75,487
| -8% | -$1.86M | 0.12% | 153 |
|
|
2025
Q2 | $21.7M | Sell |
893,506
-190,258
| -18% | -$4.44M | 0.13% | 150 |
|
|
2025
Q1 | $27.5M | Sell |
1,083,764
-1,346
| -0.1% | -$35.2K | 0.17% | 124 |
|
|
2024
Q4 | $28.8M | Buy |
1,085,110
+139,620
| +15% | +$3.79M | 0.17% | 123 |
|
|
2024
Q3 | $27.4M | Sell |
945,490
-136,065
| -13% | -$3.97M | 0.16% | 115 |
|
|
2024
Q2 | $30.3M | Buy |
1,081,555
+405,144
| +60% | +$11.2M | 0.18% | 110 |
|
|
2024
Q1 | $18.8M | Buy |
676,411
+26,475
| +4% | +$735K | 0.13% | 125 |
|
|
2023
Q4 | $18.7M | Buy |
649,936
+136,587
| +27% | +$4.13M | 0.15% | 117 |
|
|
2023
Q3 | $17M | Buy |
513,349
+3,341
| +0.7% | +$118K | 0.16% | 108 |
|
|
2023
Q2 | $18.7M | Buy |
510,008
+8,071
| +2% | +$314K | 0.17% | 104 |
|
|
2023
Q1 | $20.5M | Buy |
501,937
+3,883
| +0.8% | +$168K | 0.21% | 82 |
|
|
2022
Q4 | $25.5M | Sell |
498,054
-57,954
| -10% | -$2.78M | 0.28% | 71 |
|
|
2022
Q3 | $24.3M | Sell |
556,008
-97,238
| -15% | -$4.73M | 0.27% | 72 |
|
|
2022
Q2 | $34.3M | Sell |
653,246
-214,641
| -25% | -$10.9M | 0.32% | 62 |
|
|
2022
Q1 | $44.9M | Sell |
867,887
-118,138
| -12% | -$6.13M | 0.29% | 65 |
|
|
2021
Q4 | $58.2M | Sell |
986,025
-49,243
| -5% | -$2.44M | 0.33% | 60 |
|
|
2021
Q3 | $44.5M | Buy |
1,035,268
+2,503
| +0.2% | +$111K | 0.26% | 70 |
|
|
2021
Q2 | $40.4M | Buy |
1,032,765
+120,064
| +13% | +$4.67M | 0.25% | 78 |
|
|
2021
Q1 | $33.1M | Sell |
912,701
-27,830
| -3% | -$988K | 0.24% | 79 |
|
|
2020
Q4 | $34.6M | Sell |
940,531
-76,435
| -8% | -$2.8M | 0.24% | 87 |
|
|
2020
Q3 | $35.4M | Buy |
1,016,966
+81,625
| +9% | +$2.86M | 0.29% | 77 |
|
|
2020
Q2 | $29M | Buy |
935,341
+297,306
| +47% | +$10.1M | 0.29% | 77 |
|
|
2020
Q1 | $19.8M | Sell |
638,035
-737,632
| -54% | -$25.1M | 0.33% | 67 |
|
|
2019
Q4 | $51.1M | Buy |
1,375,667
+284,233
| +26% | +$10.1M | 0.38% | 69 |
|
|
2019
Q3 | $37.2M | Sell |
1,091,434
-380,021
| -26% | -$13.8M | 0.36% | 70 |
|
|
2019
Q2 | $60.5M | Buy |
1,471,455
+13,805
| +0.9% | +$548K | 0.53% | 41 |
|
|
2019
Q1 | $58.7M | Sell |
1,457,650
-613,641
| -30% | -$24.6M | 0.52% | 41 |
|
|
2018
Q4 | $85.8M | Buy |
2,071,291
+184,130
| +10% | +$7.64M | 0.76% | 23 |
|
|
2018
Q3 | $78.9M | Sell |
1,887,161
-545,782
| -22% | -$21M | 0.83% | 18 |
|
|
2018
Q2 | $83.7M | Sell |
2,432,943
-535,854
| -18% | -$18.3M | 0.74% | 26 |
|
|
2018
Q1 | $100M | Sell |
2,968,797
-279,798
| -9% | -$9.62M | 0.76% | 20 |
|
|
2017
Q4 | $112M | Buy |
3,248,595
+424,381
| +15% | +$14.5M | 0.79% | 21 |
|
|
2017
Q3 | $95.7M | Buy |
2,824,214
+93,747
| +3% | +$3.01M | 0.74% | 25 |
|
|
2017
Q2 | $87M | Sell |
2,730,467
-200,297
| -7% | -$6.32M | 0.69% | 29 |
|
|
2017
Q1 | $95.1M | Buy |
2,930,764
+123,117
| +4% | +$3.88M | 0.75% | 25 |
|
|
2016
Q4 | $86.5M | Buy |
2,807,647
+339,380
| +14% | +$10.4M | 0.76% | 26 |
|
|
2016
Q3 | $79.3M | Sell |
2,468,267
-545,135
| -18% | -$18.2M | 0.8% | 23 |
|
|
2016
Q2 | $101M | Buy |
3,013,402
+15,666
| +0.5% | +$500K | 0.88% | 18 |
|
|
2016
Q1 | $84.3M | Buy |
2,997,736
+92,158
| +3% | +$2.63M | 0.79% | 21 |
|
|
2015
Q4 | $89M | Sell |
2,905,578
-35,334
| -1% | -$1.11M | 0.86% | 18 |
|
|
2015
Q3 | $87.6M | Sell |
2,940,912
-3,669
| -0.1% | -$118K | 0.9% | 16 |
|
|
2015
Q2 | $93.7M | Sell |
2,944,581
-126,533
| -4% | -$4.12M | 0.89% | 15 |
|
|
2015
Q1 | $101M | Sell |
3,071,114
-325,753
| -10% | -$10.4M | 0.92% | 13 |
|
|
2014
Q4 | $100M | Sell |
3,396,867
-67,308
| -2% | -$1.93M | 0.83% | 20 |
|
|
2014
Q3 | $97.2M | Sell |
3,464,175
-221,929
| -6% | -$6.23M | 0.82% | 20 |
|
|
2014
Q2 | $104M | Buy |
3,686,104
+62,463
| +2% | +$1.78M | 0.84% | 21 |
|
|
2014
Q1 | $110M | Sell |
3,623,641
-459,667
| -11% | -$13.7M | 0.93% | 15 |
|
|
2013
Q4 | $119M | Sell |
4,083,308
-226,361
| -5% | -$6.59M | 0.94% | 14 |
|
|
2013
Q3 | $117M | Sell |
4,309,669
-411,992
| -9% | -$11.2M | 0.99% | 13 |
|
|
2013
Q2 | $125M | Buy |
+4,721,661
| New | +$130M | 1.03% | 15 |
|
Other funds holding PFE
VCM
VPM
British Columbia Investment Management's PFE Position: Q1 2026 in Review
British Columbia Investment Management reduced its Pfizer (PFE) stake by 22% in Q1 2026, selling an estimated $6M and leaving 783,617 shares worth $22M. The position accounts for 0.13% of the portfolio, ranked #130.
British Columbia Investment Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $125M in Q2 2013. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- British Columbia Investment Management held 783,617 shares of Pfizer worth $22M as of Q1 2026.
- British Columbia Investment Management sold 225,257 Pfizer shares in Q1 2026, an estimated $6M.
- Pfizer made up 0.13% of British Columbia Investment Management's portfolio in Q1 2026, its #130 holding.
- British Columbia Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- British Columbia Investment Management's Pfizer position peaked at $125M in Q2 2013.
- 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.